Phase II trial of alternate schedule of chemotherapy as front-line treatment in metastatic non-small cell lung cancer (NSCLC): A single-centre experience

被引：0
|
作者：
Lopez Castro, R. [1 ]
Martin, G. [1 ]
Seijas, R. [1 ]
Bellido, L. [1 ]
del Barco, E. [1 ]
Garcia, R. [1 ]
Martin, T. [1 ]
Castro, E. [1 ]
Leno, R. [1 ]
Cruz, J. [1 ]
机构：
[1] Univ Hosp Salamanca, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19120
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC)
    Reck, M
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1501 - 1506
  • [42] Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC) - A dose-optimizing Phase II trial
    Hirsh, V
    Whittom, R
    Ofiara, L
    Desjardins, P
    Ayoub, J
    Charpentier, D
    Small, D
    Pintos, J
    Langleben, A
    CANCER, 2003, 97 (09) : 2242 - 2247
  • [43] Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre
    Fletcher, J.
    Mullally, W. J.
    Berman, C.
    Ladwa, R.
    Xu, W.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S628 - S629
  • [44] Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
    Shafique, Michael
    Tanvetyanon, Tawee
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 225 - 232
  • [45] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [46] Experience of erlotinib for non-small cell lung cancer (NSCLC) at the Exeter Oncology Centre
    Minear, F. G.
    Ward, A. J.
    Dorey, N. E.
    Osborne, M. E.
    Toy, E. W.
    LUNG CANCER, 2011, 71 : S8 - S8
  • [47] The Checkpoint Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
    Hirsh, Vera
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [48] A PHASE 2 TRIAL OF LINIFANIB TREATMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Tan, E.
    Goss, G. D.
    Salgia, R.
    Besse, B.
    Gandara, D. R.
    Hanna, N.
    Ricker, J. L.
    Qian, J.
    Carlson, D. M.
    Soo, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 139 - 139
  • [49] Chemotherapy in elderly patients with advanced lung cancer - Part II: Treatment of non-small cell lung cancer (NSCLC)
    Honecker, F
    Wedding, U
    Bokemeyer, C
    ONKOLOGIE, 2004, 27 (06): : 583 - 588
  • [50] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
12345